BioAdaptives Inc (BDPT)

[powerbattles]

PENDING A GLOBAL DRUG SPIN-OFF:))) Massive upside coming...

Folks aren’t buying for what the company currently has…they’re buying for the massive potential of this #biotech stock after all the news/PR’s in March & April. New BOD’s & licensing to NEW products w/patents valued at over $750 million…the spin-off is coming; also ties to #AI

$BDPT This company stands out as one of the most solid and fundamentally strong investments I've come across in my years of researching of companies on the OTC market. It's a true gem worth considering.

DD part # 1 Good times ahead! SPIN-OFF
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172123754

It appears that the company is poised for the next phase of growth. The recent high-profile recruitments at BioAdaptives since April 2023 have been incredibly exciting for the company. These recruitments include top-notch professionals who are prepared to take us to the next level, potentially even securing a listing on a larger exchange.

CEO Dr. Edward E. Jacobs
Patents by Inventor Edward E. Jacobs, Jr.
https://patents.justia.com/inventor/edward-e-jacobs-jr
https://podcasts.apple.com/be/podcast/natural-green-living/id1523571157?l=nl

CEO Dr. Edward E. Jacobs Graduated the best Ivy League school Leagues. Graduate of Harvard Medical school and Princeton University. IVY Legue School ranked
1 - HARVARD
2 - PRINCETON
https://prepexpert.com/ivy-league-school-rankings/#:~:text=Ivy%20League%20Schools%3A%20Ranked%201%201.%20Harvard%20Harvard,7%207.%20Dartmouth%20...%208%208.%20Cornell%20

Recent announcements of new board members, an upcoming spin-off, new products/patents/licensing agreements, and more.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172165338

FOUR REASONS WHY WE CAN ASSURE DILUTE IS OVER.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172260092